UBS Group reaffirmed their neutral rating on shares of Siemens Healthineers (ETR:SHL) in a research report released on Monday morning, Borsen Zeitung reports.
A number of other equities research analysts have also recently weighed in on SHL. Nord/LB set a €52.00 ($60.47) price target on Siemens Healthineers and gave the company a buy rating in a report on Tuesday, February 4th. Independent Research set a €44.00 ($51.16) price target on Siemens Healthineers and gave the company a neutral rating in a report on Wednesday, February 5th. JPMorgan Chase & Co. set a €37.10 ($43.14) target price on Siemens Healthineers and gave the company a sell rating in a research note on Tuesday, February 4th. Berenberg Bank set a €50.00 ($58.14) target price on Siemens Healthineers and gave the company a buy rating in a research note on Friday, February 7th. Finally, Morgan Stanley set a €39.00 ($45.35) target price on Siemens Healthineers and gave the company a sell rating in a research note on Friday, December 6th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of €41.38 ($48.12).
Siemens Healthineers stock opened at €36.09 ($41.97) on Monday. The company has a debt-to-equity ratio of 5.01, a current ratio of 1.32 and a quick ratio of 0.87. The company has a market capitalization of $36.07 billion and a PE ratio of 23.62. Siemens Healthineers has a one year low of €31.42 ($36.53) and a one year high of €45.20 ($52.56). The business has a 50 day simple moving average of €37.30 and a 200 day simple moving average of €39.66.
About Siemens Healthineers
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Further Reading: What is a Fiduciary?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.